JPH1015087A - Method for charged particle nuclear therapy and device therefor - Google Patents

Method for charged particle nuclear therapy and device therefor

Info

Publication number
JPH1015087A
JPH1015087A JP8174571A JP17457196A JPH1015087A JP H1015087 A JPH1015087 A JP H1015087A JP 8174571 A JP8174571 A JP 8174571A JP 17457196 A JP17457196 A JP 17457196A JP H1015087 A JPH1015087 A JP H1015087A
Authority
JP
Japan
Prior art keywords
particle beam
patient
charged particle
eyelid
irradiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8174571A
Other languages
Japanese (ja)
Inventor
Koji Matsuda
浩二 松田
Kazuo Hiramoto
和夫 平本
Hiroshi Akiyama
秋山  浩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hitachi Ltd
Original Assignee
Hitachi Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hitachi Ltd filed Critical Hitachi Ltd
Priority to JP8174571A priority Critical patent/JPH1015087A/en
Publication of JPH1015087A publication Critical patent/JPH1015087A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1014Intracavitary radiation therapy
    • A61N5/1017Treatment of the eye, e.g. for "macular degeneration"
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1085X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy characterised by the type of particles applied to the patient
    • A61N2005/1087Ions; Protons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1048Monitoring, verifying, controlling systems and methods
    • A61N5/1064Monitoring, verifying, controlling systems and methods for adjusting radiation treatment in response to monitoring

Abstract

PROBLEM TO BE SOLVED: To always exactly irradiate a lesion with particle beams only when an eyelid is opened and to provide therapy while reducing the burden on a patient by measuring the action of the eyelid of the patient, eyeball or the both and synchronizing the operating parameter of a charged particle nuclear irradiating device with this action. SOLUTION: An accelerator system 1 generates particle beams required for therapy, an irradiation field forming device 5 adjusts beam form and energy distribution and sets them corresponding to the position and form of the lesion at the eyebottom of a patient 6, and head is fixed by a fixer 7. A monitor camera 8 monitors the action on te eyeball or the opening/closing of the eyelid of the patient 6, sends image information to a glance monitor 9 and outputs image signals to a judging device 1. The judging device 21 compares these signals with information in a storage device 22 and, when they are settled within the allowable range, a signal is sent from the judging device 21 to a beam extraction controller 10 so that the lesion can be irradiated with beams. An irradiation dose rate is monitored by a dose monitor, a synchrotron operation controller 24 accumulates the dose rate and, when the total irradiation dose is achieved, irradiation is finished.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、荷電粒子線治療方
法と荷電粒子線治療装置に関する。
The present invention relates to a charged particle beam therapy method and a charged particle beam therapy device.

【0002】[0002]

【従来の技術】従来技術は、特開昭59−88160 号公報
に、患部の3次元的な位置を超音波断層装置によって測
定し、放射線照射範囲を制御する放射線制御装置が記載
されている。また、特開平1−232959 号公報に、眼球の
動きに追従して治療用のレーザ光を所定位置に照射する
角膜治療装置が記載されている。
2. Description of the Related Art As a prior art, Japanese Patent Laid-Open Publication No. Sho 59-88160 describes a radiation control apparatus for measuring a three-dimensional position of an affected part by an ultrasonic tomography apparatus and controlling a radiation irradiation range. Japanese Patent Application Laid-Open No. 1-2232959 discloses a corneal treatment apparatus that irradiates a predetermined position with a treatment laser beam following the movement of an eyeball.

【0003】[0003]

【発明が解決しようとする課題】一般に陽子線や重粒子
線による荷電粒子線治療は、線量照射の位置分解能が良
く、患部へ的確に線量照射できるという利点を持つ。こ
の性質は眼の癌(メラノーマ)の治療の場合には、患部
のすぐ奥にある神経組織や脳の被爆が少ないので特に有
効である。しかし眼の治療の場合、患者が瞬きをすれ
ば、まぶたの厚さだけ荷電粒子線照射位置がずれてしま
う。また、患者の視線が逸れ眼球が動けば、それだけ荷
電粒子線照射位置がずれてしまう。しかし、荷電粒子線
は照射位置,範囲の変更が容易でなく、素早く適切な照
射範囲変更を実現するには、複雑で巨大な装置を必要と
し、実現困難である。そこで従来は、治療に必要な間眼
球およびまぶたを固定して、癌患部の位置とそこまでの
深さを一定にする。この固定に伴い、患者に不快感を与
えるので、より患者の負担の少ない治療方法の開発が望
まれている。
Generally, charged particle beam therapy using a proton beam or a heavy particle beam has an advantage that the positional resolution of dose irradiation is good and the dose can be accurately irradiated to an affected part. This property is particularly effective in the treatment of eye cancer (melanoma) because the nerve tissue and the brain immediately behind the affected area are less exposed. However, in the case of eye treatment, if the patient blinks, the charged particle beam irradiation position shifts by the thickness of the eyelid. Further, if the patient's line of sight deviates and the eyeball moves, the charged particle beam irradiation position shifts accordingly. However, it is not easy to change the irradiation position and range of the charged particle beam, and it is difficult to change the irradiation range quickly and appropriately because a complicated and huge device is required and it is difficult to realize the change. Therefore, conventionally, the eyeballs and eyelids necessary for the treatment are fixed, and the position of the affected part of the cancer and the depth to the part are fixed. Since this fixation gives the patient discomfort, there is a demand for the development of a treatment method with less burden on the patient.

【0004】[0004]

【課題を解決するための手段】上記の課題を解決するた
めの第一の手段は、患者のまぶたおよび眼球の動きを測
定し、患者の視線のずれが小さく、まぶたが開いた状態
の間又は閉じた状態の間のみ荷電粒子線を照射すること
である。
A first means for solving the above-mentioned problem is to measure the movement of the patient's eyelids and eyeballs, and to minimize the deviation of the patient's line of sight, and to measure whether the eyelids are open or not. Irradiating the charged particle beam only during the closed state.

【0005】第二の手段は、患者のまぶたが開いている
場合と閉じている場合とで、患者前面での荷電粒子線の
エネルギを変更することである。
[0005] The second means is to change the energy of the charged particle beam in front of the patient depending on whether the patient's eyelid is open or closed.

【0006】上記第一の手段によれば、荷電粒子線を照
射している間の患部までの深さおよび位置が一定なの
で、常に患部を的確に照射することができる。患者の眼
球およびまぶたを固定する必要がなくなり、患者の負担
の少ない治療を実現できる。また、照射範囲を変更しな
いので、簡易な装置および制御によって的確な線量照射
を実現できる。
According to the first means, since the depth and the position to the affected part are constant during the irradiation of the charged particle beam, the affected part can always be accurately irradiated. There is no need to fix the patient's eyeballs and eyelids, and a treatment with less burden on the patient can be realized. In addition, since the irradiation range is not changed, accurate dose irradiation can be realized with a simple device and control.

【0007】第二の手段によれば、荷電粒子線のエネル
ギを変更することで、まぶたの開閉によらず患部までの
深さを一定に調節でき、常に患部を的確に照射すること
ができる。患者の眼球およびまぶたを固定する必要がな
くなり、患者の負担の少ない治療を実現できる。
According to the second means, by changing the energy of the charged particle beam, the depth to the affected part can be adjusted to be constant regardless of the opening and closing of the eyelid, and the affected part can always be accurately irradiated. There is no need to fix the patient's eyeballs and eyelids, and a treatment with less burden on the patient can be realized.

【0008】[0008]

【発明の実施の形態】図1は、患者のまぶた及び眼球の
状態に対応してシンクロトロンの運転を制御し、患者へ
の粒子ビーム照射のタイミングを制御する本発明の第1
の実施例の装置構成を表わす。図中の1は、イオン源,
前段加速器,シンクロトロン2からなる加速器システム
であり、治療に必要な高エネルギ粒子ビームを発生す
る。シンクロトロンで加速された粒子ビームは、摂動電
磁場を用いた遅い取り出し法と呼ばれる手法を用いてシ
ンクロトロン外へ取り出す。以下に前記取り出し手法に
ついて述べる。シンクロトロン内部を周回する粒子ビー
ムは、進行方向と垂直方向にベータトロン振動と呼ばれ
る振動運動を行っている。加速が終了すると、シンクロ
トロン内の電磁石の磁場強度を調節して、ベータトロン
振動運動を共鳴状態に近い状態にする。次に摂動電磁場
印加装置3によってベータトロン振動の周波数に近い周
波数を持つ摂動電磁場を印加することで、粒子ビームの
ベータトロン振動振幅は増大し、出射器4を通じてシン
クロトロン外部へ取り出される。粒子ビームは摂動電磁
場を印加し続けている間は供給され続けるが、摂動電磁
場の印加を一時停止すると粒子ビームも一時停止する。
ビーム取り出し制御装置10は、外部からの信号入力で
摂動電場をオン,オフすることで、シンクロトロンから
取り出す粒子ビームの時間構造を制御する。
DESCRIPTION OF THE PREFERRED EMBODIMENTS FIG. 1 shows a first embodiment of the present invention for controlling the operation of a synchrotron in accordance with the condition of the eyelids and eyeballs of a patient and controlling the timing of irradiation of a particle beam to the patient.
1 shows an apparatus configuration of the embodiment. 1 in the figure is an ion source,
This is an accelerator system composed of a pre-stage accelerator and a synchrotron 2, and generates a high energy particle beam required for treatment. The particle beam accelerated by the synchrotron is extracted out of the synchrotron using a method called a slow extraction method using a perturbed electromagnetic field. The following describes the extraction method. The particle beam orbiting inside the synchrotron makes an oscillatory motion called betatron oscillation in the direction perpendicular to the traveling direction. When the acceleration is completed, the intensity of the magnetic field of the electromagnet in the synchrotron is adjusted to bring the betatron oscillation motion closer to the resonance state. Next, by applying a perturbation electromagnetic field having a frequency close to the frequency of the betatron oscillation by the perturbation electromagnetic field applying device 3, the amplitude of the betatron oscillation of the particle beam increases, and the particle beam is taken out of the synchrotron through the emitter 4. The particle beam is continuously supplied while the perturbation electromagnetic field is continuously applied, but when the application of the perturbation electromagnetic field is temporarily stopped, the particle beam is also temporarily stopped.
The beam extraction control device 10 controls the time structure of the particle beam extracted from the synchrotron by turning on and off the perturbation electric field in response to an external signal input.

【0009】取り出された粒子ビームは、照射野形成装
置5によってビーム形状,エネルギ分布を調節される。
照射野形成装置5は、治療計画時に患者6の眼底にある
患部の位置,形状に合わせて設定する。治療のあいだ患
者の頭部は固定具7によって固定される。監視カメラ8
は、患者の眼球の動き及びまぶたの開閉状態を監視し、
画像情報を視線モニタ9に送る。視線モニタ9は、画像
情報を処理し、まぶたおよび眼球の位置,向きを定量的
に表わす信号を、判断装置21に出力する。判断装置2
1は、信号を、治療計画時に設定された条件を記憶した
記憶装置22の情報と比較し、許容範囲内にあるかどう
かを判定する。許容範囲を超えた場合は、ビーム取り出
し制御装置10に信号を送り、摂動電磁場の印加を一時
停止してビーム照射を一時停止する。まぶたおよび眼球
の位置,向きが、再び許容範囲内へ戻れば、判断装置2
1からビーム取り出し制御装置10に信号を送り、再度
摂動電磁場を印加してビーム照射を再開する。患者に照
射している線量率は、線量モニタ23によって測定さ
れ、シンクロトロン運転制御装置24に測定値が出力さ
れる。シンクロトロン運転制御装置24は、線量率を積
算し、積算線量が治療計画で設定された総照射線量に達
すると、照射を終了する。図10に本実施例での装置の
動作を表わすフローチャートを示す。
The extracted particle beam is adjusted in beam shape and energy distribution by an irradiation field forming device 5.
The irradiation field forming device 5 is set in accordance with the position and shape of the affected part on the fundus of the patient 6 at the time of treatment planning. During treatment, the patient's head is fixed by the fixture 7. Surveillance camera 8
Monitors the movement of the patient's eyeballs and the open / closed state of the eyelids,
The image information is sent to the eye monitor 9. The eye gaze monitor 9 processes the image information and outputs to the determination device 21 a signal that quantitatively represents the positions and directions of the eyelids and the eyeball. Judgment device 2
1 compares the signal with information in the storage device 22 that stores conditions set at the time of treatment planning, and determines whether the signal is within an allowable range. If it exceeds the allowable range, a signal is sent to the beam extraction control device 10 to temporarily stop the application of the perturbation electromagnetic field and temporarily stop the beam irradiation. If the positions and orientations of the eyelids and the eyeball return to the allowable range again, the determination device 2
From 1, a signal is sent to the beam extraction control device 10, a perturbation electromagnetic field is applied again, and beam irradiation is restarted. The dose rate irradiating the patient is measured by the dose monitor 23, and the measured value is output to the synchrotron operation control device 24. The synchrotron operation control device 24 accumulates the dose rates, and ends the irradiation when the accumulated dose reaches the total irradiation dose set in the treatment plan. FIG. 10 is a flowchart showing the operation of the apparatus in this embodiment.

【0010】図2に、患者の眼の状態と、ビーム照射部
分を示す。図2(a)は、患者のまぶたおよび眼球の位
置,向きが許容範囲内にある場合の照射状態を示してい
る。患者の眼球11の奥にある患部12において線量分
布が高くなるように、シンクロトロンからの粒子ビーム
のエネルギと、照射野形成装置の一部である散乱体5a
及びコリメータ5bを設定している。患者に照射される
線量率は、線量モニタ23によって測定される。図2
(b)はまぶた13が閉まった場合、図2(c)は眼球が
動き、視線が逸れた場合であり、正常組織への照射を抑
制するために、シンクロトロンからの粒子ビームを一時
停止する。なお、図8(a),図8(b)に、まぶたが閉
まった状態で粒子ビームを照射した場合に、照射範囲が
ずれる様子を示す。図3に、視線モニタ9から出力され
る信号と、シンクロトロンからの粒子ビーム電流の時間
変化の一例を示す。図中の「視線」および「まぶたの開
量」は、視線モニタ9から出力される信号のうち、それ
ぞれ視線の向きとまぶたの状態を表わす信号である。治
療計画時に設定される許容範囲を時間軸に平行な点線で
示す。視線は、時間軸を挟む2本の点線の内部が許容範
囲である。まぶたの開量は、1本の点線より下側が許容
範囲である。この範囲を超えると、摂動電磁場強度を0
にして粒子ビーム電流を0にする。即ち粒子ビーム照射
を一時停止する。それぞれのタイミングの関係を、時間
軸に垂直な点線で示した。
FIG. 2 shows a state of a patient's eye and a beam irradiation portion. FIG. 2A shows an irradiation state when the positions and orientations of the patient's eyelids and eyeballs are within an allowable range. The energy of the particle beam from the synchrotron and the scatterer 5a, which is a part of the irradiation field forming device, are set so that the dose distribution becomes higher in the affected part 12 located behind the eyeball 11 of the patient.
And a collimator 5b. The dose rate applied to the patient is measured by the dose monitor 23. FIG.
2B shows the case where the eyelid 13 is closed, and FIG. 2C shows the case where the eyeball moves and the line of sight is deviated. In order to suppress the irradiation of the normal tissue, the particle beam from the synchrotron is temporarily stopped. . FIGS. 8A and 8B show how the irradiation range shifts when the particle beam is irradiated with the eyelids closed. FIG. 3 shows an example of a signal output from the line-of-sight monitor 9 and a temporal change of the particle beam current from the synchrotron. The “line of sight” and “opening amount of the eyelid” in the figure are signals representing the direction of the line of sight and the state of the eyelid, respectively, of the signals output from the line-of-sight monitor 9. The permissible range set at the time of treatment planning is indicated by a dotted line parallel to the time axis. The line of sight is within an allowable range between two dotted lines sandwiching the time axis. The lower limit of the eyelid opening below one dotted line is an allowable range. Beyond this range, the perturbation field strength becomes zero
To set the particle beam current to zero. That is, the particle beam irradiation is temporarily stopped. The relationship between the respective timings is shown by a dotted line perpendicular to the time axis.

【0011】なお、ビームを一時停止する方法は、サイ
クロトロンのような擬連続的にビームを発生する加速器
の場合、イオン源から供給される低エネルギ粒子ビーム
を遮断しても良い。
The beam may be temporarily stopped by cutting off the low energy particle beam supplied from the ion source in the case of an accelerator such as a cyclotron which generates a beam in a quasi-continuous manner.

【0012】また、患者のまぶたおよび眼球の動きを測
定する方法は、電極を患者頭部の眼の周りに接触させ、
筋電図を取る方法や、レーザ等の光の反射率をモニタす
る方法でも良い。
A method for measuring eyelid and eye movement of a patient includes contacting the electrodes around the eyes of the patient's head,
A method of taking an electromyogram or a method of monitoring the reflectance of light such as a laser may be used.

【0013】図4は、患者のまぶた及び眼球の状態に対
応してビーム遮断器を制御し、患者へのビーム照射のタ
イミングを制御する本発明第2の実施例の装置構成を表
わす。加速器1から供給される粒子ビームは、照射野形
成装置5によってビーム形状,エネルギ分布を調節さ
れ、患者6の眼底にある患部へ照射される。治療のあい
だ患者6の頭部は固定具7によって固定される。監視カ
メラ8は、患者6の眼球の動き及びまぶたの開閉状態を
監視し、画像情報を視線モニタ9に送る。視線モニタ9
は、画像情報を処理し、まぶたおよび眼球の位置,向き
を定量的に表わす信号を、判断装置21に出力する。判
断装置21は、信号を、治療計画時に設定された条件を
記憶した記憶装置22の情報と比較し、許容範囲内にあ
るかどうかを判定する。許容範囲を超えた場合は、ビー
ム遮断器制御装置14に信号を送り、ビーム遮断器15
を閉めて粒子ビーム照射を一時停止する。まぶたおよび
眼球の位置,向きが、再び許容範囲内へ戻れば、判断装
置21からビーム遮断器制御装置14に信号を送り、再
度遮断器15を開いて粒子ビーム照射を再開する。患者
に照射している線量率は、線量モニタ23によって測定
され、加速器運転制御装置25に測定値が出力される。
加速器運転制御装置25は、線量率を積算し、積算線量
が治療計画で設定された総照射線量に達すると、照射を
終了する。
FIG. 4 shows the configuration of an apparatus according to a second embodiment of the present invention, which controls a beam breaker in accordance with the state of the eyelids and eyes of a patient and controls the timing of beam irradiation on the patient. The beam shape and the energy distribution of the particle beam supplied from the accelerator 1 are adjusted by the irradiation field forming device 5, and the particle beam is irradiated on the affected part on the fundus of the patient 6. During treatment, the head of the patient 6 is fixed by the fixture 7. The monitoring camera 8 monitors the movement of the eyeball of the patient 6 and the open / closed state of the eyelids, and sends image information to the eye gaze monitor 9. Eye gaze monitor 9
Processes the image information and outputs to the determination device 21 a signal quantitatively representing the positions and orientations of the eyelids and the eyeball. The determination device 21 compares the signal with information in a storage device 22 that stores conditions set at the time of treatment planning, and determines whether the signal is within an allowable range. If it exceeds the allowable range, a signal is sent to the beam breaker control device 14 and the beam breaker 15
Is closed to suspend the particle beam irradiation. When the positions and orientations of the eyelids and the eyeball return to the allowable ranges again, a signal is sent from the determination device 21 to the beam breaker control device 14, and the breaker 15 is opened again to restart the particle beam irradiation. The dose rate irradiating the patient is measured by the dose monitor 23, and the measured value is output to the accelerator operation control device 25.
The accelerator operation control device 25 accumulates the dose rates, and terminates the irradiation when the accumulated dose reaches the total irradiation dose set in the treatment plan.

【0014】図5に患者の眼の状態と、ディグレーダ1
6と偏向電磁石17,ビームダンパ18から構成される
ビーム遮断器15の開閉状態及びビーム照射部分を示
す。粒子ビーム照射中は、図5(a)のようにディグレ
ーダ16が開いているが、まぶた13が閉まった場合
(図5(b))や眼球が動き、視線が逸れた場合(図5
(c))は、ディグレーダ16が閉じる。粒子ビームは
閉じたディグレーダを通過することでエネルギが低くな
り、下流の偏向電磁石17での偏向角度が大きくなって
軌道が逸れ、ビームダンパ18へ到達して止まる。薄い
ディグレーダを使った構成にすることによって、短いビ
ーム遮断反応時間を得る。図6に、視線モニタ9から出
力される信号と、ビーム遮断器の一部であるディグレー
ダの開閉状況,粒子ビーム照射状況の時間変化の一例を
示す。図3と同様に治療計画時に設定される許容範囲を
時間軸に平行な点線で、タイミングの関係を時間軸に垂
直な点線で示す。許容範囲を超えると、ディグレーダを
閉じてビーム電流を0にする。即ち粒子ビーム照射を一
時停止する。
FIG. 5 shows the condition of the patient's eye and the degrader 1.
6 shows the open / closed state of a beam breaker 15 composed of a magnet 6, a bending electromagnet 17, and a beam damper 18 and a beam irradiation portion. During particle beam irradiation, the degrader 16 is open as shown in FIG. 5 (a), but the eyelid 13 is closed (FIG. 5 (b)) or the eye moves and the line of sight is deviated (FIG. 5 (b)).
In (c)), the degrader 16 is closed. The energy of the particle beam is reduced by passing through the closed degrader, the deflection angle at the downstream bending electromagnet 17 is increased, the trajectory is deviated, and the particle beam reaches the beam damper 18 and stops. By using a configuration using a thin degrader, a short beam cutoff reaction time is obtained. FIG. 6 shows an example of a signal output from the line-of-sight monitor 9 and a time change of the opening / closing state of the degrader, which is a part of the beam breaker, and the particle beam irradiation state. Similar to FIG. 3, the allowable range set at the time of treatment planning is indicated by a dotted line parallel to the time axis, and the timing relationship is indicated by a dotted line perpendicular to the time axis. If it exceeds the allowable range, the degrader is closed to reduce the beam current to zero. That is, the particle beam irradiation is temporarily stopped.

【0015】なお、ビーム遮断器は、粒子ビームを完全
に一時停止するだけの厚みを持つディグレーダを使用
し、下流に偏向電磁石を配置しない構成や、キッカー電
磁石とビームダンパの構成でもよい。
The beam breaker may use a degrader having a thickness enough to temporarily stop the particle beam completely, and may have a configuration in which a bending electromagnet is not disposed downstream or a configuration in which a kicker electromagnet and a beam damper are provided.

【0016】図7は、患者のまぶたの開閉状態に対応し
て、患者へ照射する粒子ビームのエネルギを制御する本
発明の第3の実施例の装置構成を表わす。加速器1から
供給される粒子ビームは、照射野形成装置5によってビ
ーム形状,エネルギ分布を調節される。照射範囲は、ま
ぶたが開き、シャッタ型ディグレーダ20を閉じた状態
で、患部に粒子ビームが照射されるように設定する。患
者6の眼底にある患部へ照射される。治療のあいだ患者
の頭部は固定具7によって固定される。監視カメラ8
は、患者のまぶたの開閉状態を監視し、画像情報を視線
モニタ9に送る。視線モニタ9は、画像情報を処理し、
まぶたの開閉の状態を定量的に表わす信号を、判断装置
21に出力する。判断装置21は、信号を、治療計画時
に設定された条件を記憶した記憶装置22の情報と比較
し、許容範囲内にある(まぶたが開いている)かどうか
を判定する。許容範囲を超えた(まぶたが閉じた)と判
定した場合は、照射深さ制御装置19に信号を送り、粒
子ビームエネルギを調節して照射深さをまぶたの厚さ分
だけ深くする。再び許容範囲内へ戻れば(まぶたが開け
ば)、判断装置21から照射深さ制御装置19に信号を
送り、再度粒子ビームのエネルギを基へ戻して照射深さ
をまぶたが開いた状態の深さに戻す。判断装置21は、
まぶたの開量が許容範囲を超えてからの時間を計測し、
事前に設定した長さの時間を超えてもまぶたの開量が許
容範囲に戻らない場合は、ビーム照射を一時停止する。
ビームエネルギを患者に照射している線量率は、線量モ
ニタ23によって測定され、加速器運転制御装置25に
測定値が出力される。加速器運転制御装置25は、線量
率を積算し、積算線量が治療計画で設定された総照射線
量に達すると、照射を終了する。
FIG. 7 shows the configuration of an apparatus according to a third embodiment of the present invention for controlling the energy of a particle beam applied to a patient in accordance with the eyelid opening / closing state of the patient. The beam shape and energy distribution of the particle beam supplied from the accelerator 1 are adjusted by the irradiation field forming device 5. The irradiation range is set so that the affected part is irradiated with the particle beam with the eyelids open and the shutter type degrader 20 closed. Irradiation is performed on the affected area on the fundus of the patient 6. During treatment, the patient's head is fixed by the fixture 7. Surveillance camera 8
Monitors the open / closed state of the patient's eyelids and sends image information to the eye monitor 9. The eye gaze monitor 9 processes the image information,
A signal quantitatively representing the state of opening and closing of the eyelid is output to the determination device 21. The determination device 21 compares the signal with information in the storage device 22 that stores conditions set at the time of treatment planning, and determines whether the signal is within an allowable range (eyelids are open). If it is determined that the permissible range is exceeded (the eyelid is closed), a signal is sent to the irradiation depth control device 19 to adjust the particle beam energy to increase the irradiation depth by the thickness of the eyelid. When the eyelids return to the allowable range again (if the eyelids are opened), a signal is sent from the determination device 21 to the irradiation depth control device 19, and the energy of the particle beam is returned again to the irradiation depth, and the depth of the eyelids is opened. Put it back. The judgment device 21
Measure the time from when the eyelid opening exceeds the allowable range,
If the amount of eyelid opening does not return to the allowable range even after the length of time set in advance, the beam irradiation is temporarily stopped.
The dose rate at which the patient is irradiated with the beam energy is measured by the dose monitor 23, and the measured value is output to the accelerator operation control device 25. The accelerator operation control device 25 accumulates the dose rates, and terminates the irradiation when the accumulated dose reaches the total irradiation dose set in the treatment plan.

【0017】図8に、患者の眼の状態と、シャッタ型デ
ィグレーダ20を使ったビームエネルギ変更器及びビー
ム照射部分を示す。まぶたが開いている場合は、図8
(c)のようにシャッタ型ディグレーダ20を閉じてお
き、まぶた13が閉まった場合(図8(d))は、シャ
ッタ型ディグレーダ20が開く。シャッタ型ディグレー
ダ20の厚さは、粒子ビームがシャッタ型ディグレーダ
を通過することで失うエネルギが、粒子ビームがまぶた
13を通過することで失うエネルギと等しくなるように
設定する。照射範囲は、まぶたが開きシャッタ型ディグ
レーダを閉じた状態で、患部に粒子ビームが照射される
ように設定する。シャッタ型ディグレーダでのエネルギ
損失は、まぶたでのエネルギ損失と等しいため、粒子ビ
ームが、シャッタ型ディグレーダを通過してまぶたを通
過しない場合と、まぶたを通過してシャッタ型ディグレ
ーダを通過しない場合とで飛程は等しく、照射範囲も等
しくなる。
FIG. 8 shows a state of a patient's eye, a beam energy changer using a shutter type degrader 20, and a beam irradiation portion. If the eyelids are open, see FIG.
As shown in FIG. 8C, when the shutter type degrader 20 is closed and the eyelid 13 is closed (FIG. 8D), the shutter type degrader 20 is opened. The thickness of the shutter type degrader 20 is set so that the energy lost when the particle beam passes through the shutter type degrader is equal to the energy lost when the particle beam passes through the eyelid 13. The irradiation range is set so that the affected part is irradiated with the particle beam with the eyelids open and the shutter type degrader closed. Since the energy loss in the shutter-type degrader is equal to the energy loss in the eyelid, the particle beam passes through the shutter-type degrader and does not pass through the eyelid, and the particle beam passes through the eyelid and does not pass through the shutter-type degrader. The range is equal and the irradiation range is equal.

【0018】また図9に、視線モニタ9から出力される
信号と、シャッタ型ディグレーダ開閉状況および患者前
面での粒子ビームエネルギ,ビーム電流の時間変化の一
例を示す。図3と同様に治療計画時に設定される許容範
囲を時間軸に平行な点線で、タイミングの関係を時間軸
に垂直な点線で示す。許容範囲を超えると、シャッタ型
ディグレーダが開き、ビームのエネルギが上がる。また
図中の矢印は、治療計画時に設定した許容経過時間で、
視線モニタからの信号が許容範囲を超えてからこの長さ
の時間が経過しても、許容範囲内に戻らない場合は、粒
子ビームを一時停止する。照射を一時停止する方法は、
第1および第2の実施例で述べた方法で良い。
FIG. 9 shows an example of a signal output from the line-of-sight monitor 9, a shutter-type degrader opening / closing state, and a temporal change in particle beam energy and beam current in front of the patient. Similar to FIG. 3, the allowable range set at the time of treatment planning is indicated by a dotted line parallel to the time axis, and the timing relationship is indicated by a dotted line perpendicular to the time axis. If the allowable range is exceeded, the shutter degrader opens and the energy of the beam increases. The arrow in the figure is the allowable elapsed time set at the time of treatment planning,
If the signal from the line-of-sight monitor does not return within the allowable range even if the length of time has elapsed since the signal exceeded the allowable range, the particle beam is temporarily stopped. To pause irradiation,
The method described in the first and second embodiments may be used.

【0019】なお、視線の向きを測定して、第1および
第2の実施例と併用してもよい。
The direction of the line of sight may be measured and used together with the first and second embodiments.

【0020】第1の実施例によれば、患部へ照射してい
ない間、粒子ビームはシンクロトロンを周回し続け、失
われないので、粒子ビームの利用効率が向上する。同時
にビーム損失が少ないため、放射線の発生量も少ない。
また、摂動電磁場によって粒子ビームのオン,オフを制
御するため、簡単な装置構成および制御によって素早い
ビームスイッチングを実現できる。
According to the first embodiment, the particle beam continues to circulate around the synchrotron and is not lost while the irradiation of the affected part is not performed, so that the utilization efficiency of the particle beam is improved. At the same time, the amount of radiation is small because the beam loss is small.
Further, since on / off of the particle beam is controlled by the perturbation electromagnetic field, quick beam switching can be realized by a simple device configuration and control.

【0021】第2の実施例によれば、加速器を定常運転
したままで、素早いビームスイッチングを実現できる。
According to the second embodiment, quick beam switching can be realized with the accelerator operating in a steady state.

【0022】第3の実施例によれば、患者が一時的にま
ぶたを閉じた間も照射を続けられるため、粒子ビームの
利用効率が向上する。シャッタ型ディグレーダの開閉に
よって照射範囲を変更するため、簡易な装置および制御
によって的確な線量照射を実現できる。
According to the third embodiment, since the irradiation can be continued even while the patient temporarily closes the eyelids, the utilization efficiency of the particle beam is improved. Since the irradiation range is changed by opening and closing the shutter-type degrader, accurate dose irradiation can be realized with a simple device and control.

【0023】[0023]

【発明の効果】本発明によれば、患者のまぶたの開閉状
態及び眼球(視線)の動きを監視し、患者の視線のずれ
が小さく、まぶたが開いた状態の間のみ粒子ビームを照
射することで、常に患部を的確に照射することができ
る。患者の眼球およびまぶたを固定する必要がなく、患
者の負担の少ない治療を実現できる。また、照射範囲を
変更しないので、簡易な装置および制御によって的確な
線量照射を実現できる。
According to the present invention, the eyelid opening / closing state of the patient and the movement of the eyeball (line of sight) are monitored, and the particle beam is radiated only while the patient's line of sight is small and the eyelid is open. Thus, the affected area can always be accurately irradiated. There is no need to fix the patient's eyeballs and eyelids, and a treatment with less burden on the patient can be realized. In addition, since the irradiation range is not changed, accurate dose irradiation can be realized with a simple device and control.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明の第1の実施例の装置のブロック図。FIG. 1 is a block diagram of an apparatus according to a first embodiment of the present invention.

【図2】第1の実施例での装置の動作原理を示した説明
図。
FIG. 2 is an explanatory diagram showing the operation principle of the device in the first embodiment.

【図3】第1の実施例での装置の動作手順を示すタイミ
ングチャート。
FIG. 3 is a timing chart showing an operation procedure of the device in the first embodiment.

【図4】本発明の第2の実施例の装置のブロック図。FIG. 4 is a block diagram of an apparatus according to a second embodiment of the present invention.

【図5】第2の実施例での装置の動作原理を示したブロ
ック図。
FIG. 5 is a block diagram showing the operation principle of the device according to the second embodiment.

【図6】第2の実施例での装置の動作手順を示すタイミ
ングチャート。
FIG. 6 is a timing chart showing an operation procedure of the device in the second embodiment.

【図7】本発明の第3の実施例の装置のブロック図。FIG. 7 is a block diagram of an apparatus according to a third embodiment of the present invention.

【図8】第3の実施例での装置の動作原理を示したブロ
ック図。
FIG. 8 is a block diagram showing the operation principle of the device according to the third embodiment.

【図9】第3の実施例での装置の動作手順を示すタイミ
ングチャート。
FIG. 9 is a timing chart showing an operation procedure of the device in the third embodiment.

【図10】第1の実施例での装置の動作を示すフローチ
ャート。
FIG. 10 is a flowchart showing the operation of the apparatus according to the first embodiment.

【符号の説明】[Explanation of symbols]

1…加速器システム、2…シンクロトロン、3…摂動場
印加装置、4…出射器、5…照射野形成装置、6…患
者、7…固定具、8…監視カメラ、9…視線モニタ、1
0…ビーム取り出し制御装置、21…判断装置、22…
記憶装置、24…シンクロトロン運転制御装置。
DESCRIPTION OF SYMBOLS 1 ... Accelerator system, 2 ... Synchrotron, 3 ... Perturbation field applying device, 4 ... Ejector, 5 ... Irradiation field forming device, 6 ... Patient, 7 ... Fixture, 8 ... Surveillance camera, 9 ... Eye gaze monitor, 1
0: Beam extraction control device, 21: Judgment device, 22:
Storage device, 24: synchrotron operation control device.

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】患者のまぶたまたは眼球若しくはその両方
の動きを測定し、荷電粒子線照射装置の動作パラメータ
を上記動きに同期させることを特徴とする荷電粒子線照
射方法。
1. A charged particle beam irradiation method characterized by measuring the movement of a patient's eyelid and / or eyeball, and synchronizing an operation parameter of the charged particle beam irradiation device with the movement.
【請求項2】請求項1において、前記患者のまぶたの開
閉状態及び視線のずれ量を測定し、前記測定量を事前に
設定した判断条件と比較して、荷電粒子線照射のタイミ
ングを制御する荷電粒子線照射方法。
2. The charged particle beam irradiation timing according to claim 1, wherein the patient's eyelid opening / closing state and the amount of deviation of the line of sight are measured, and the measured amount is compared with a predetermined judgment condition. Charged particle beam irradiation method.
【請求項3】請求項1において、前記患者のまぶたが開
いている場合と閉じている場合とで、患者前面での荷電
粒子線のエネルギを変更する荷電粒子線照射方法。
3. The charged particle beam irradiation method according to claim 1, wherein the energy of the charged particle beam in front of the patient is changed depending on whether the patient's eyelid is open or closed.
【請求項4】請求項3において、前記荷電粒子線が通過
するときに損失するエネルギが、まぶたを通過する際の
損失エネルギとほぼ同等であるディグレーダを具備し、
前記ディグレーダをまぶたの開いている間は閉じ、閉じ
ている間は開く荷電粒子線照射方法。
4. A degrader according to claim 3, wherein energy lost when said charged particle beam passes is substantially equal to energy lost when passing through the eyelid,
A charged particle beam irradiation method in which the degrader is closed while the eyelid is open and opened while the eyelid is closed.
【請求項5】請求項2において、シンクロトロンを放射
線発生源とし、荷電粒子線照射のタイミングの切り替え
をビーム取り出しのオン,オフにより実現する荷電粒子
線照射装置。
5. A charged particle beam irradiation apparatus according to claim 2, wherein a synchrotron is used as a radiation source, and switching of charged particle beam irradiation timing is realized by turning on / off beam extraction.
【請求項6】請求項5において、ビームのベータトロン
振動の周波数に近い周波数の摂動電磁場をビームに印加
してビームを取り出す荷電粒子線照射装置。
6. A charged particle beam irradiation apparatus according to claim 5, wherein a perturbation electromagnetic field having a frequency close to the frequency of betatron oscillation of the beam is applied to the beam to extract the beam.
JP8174571A 1996-07-04 1996-07-04 Method for charged particle nuclear therapy and device therefor Pending JPH1015087A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8174571A JPH1015087A (en) 1996-07-04 1996-07-04 Method for charged particle nuclear therapy and device therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8174571A JPH1015087A (en) 1996-07-04 1996-07-04 Method for charged particle nuclear therapy and device therefor

Publications (1)

Publication Number Publication Date
JPH1015087A true JPH1015087A (en) 1998-01-20

Family

ID=15980895

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8174571A Pending JPH1015087A (en) 1996-07-04 1996-07-04 Method for charged particle nuclear therapy and device therefor

Country Status (1)

Country Link
JP (1) JPH1015087A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007080981A1 (en) * 2006-01-12 2007-07-19 National University Corporation Gunma University Device for determining aim position of charged particle beam, its using method, and treatment device employing device for determining aim position
JP2009254828A (en) * 2008-04-14 2009-11-05 National Cancer Center Method of tracking eyeball in eyeball tumor treatment
JP2018102915A (en) * 2016-12-08 2018-07-05 イオン ビーム アプリケーションズIon Beam Applications Particle treatment device for treatment of eyeball

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007080981A1 (en) * 2006-01-12 2007-07-19 National University Corporation Gunma University Device for determining aim position of charged particle beam, its using method, and treatment device employing device for determining aim position
US7952081B2 (en) 2006-01-12 2011-05-31 National University Corporation Gunma University Device for determining aim position of charged particle beam, method of using the device, and treatment device employing device for determining aim position
JP5137071B2 (en) * 2006-01-12 2013-02-06 国立大学法人群馬大学 Charged particle beam aiming position determination apparatus and treatment apparatus using the aiming position determination apparatus
JP2009254828A (en) * 2008-04-14 2009-11-05 National Cancer Center Method of tracking eyeball in eyeball tumor treatment
US8638982B2 (en) 2008-04-14 2014-01-28 National Cancer Center Method of tracking eyeball in eyeball tumor treatment
JP2018102915A (en) * 2016-12-08 2018-07-05 イオン ビーム アプリケーションズIon Beam Applications Particle treatment device for treatment of eyeball

Similar Documents

Publication Publication Date Title
JP5374731B2 (en) Laser-driven particle beam irradiation apparatus and method of operating laser-driven particle beam irradiation apparatus
KR102292728B1 (en) Apparatus for applying electromagnetic radiation to anterior surface of iris of human eye
EP2376195B1 (en) Therapeutic apparatus
JP2005124852A (en) Particle therapy system
JP2004321408A (en) Radiation irradiation device and radiation irradiation method
JP2011523169A (en) Charged particle beam extraction method and apparatus for use with a charged particle cancer treatment system
JP2009236867A (en) Charged particle beam irradiating apparatus
JPH1015087A (en) Method for charged particle nuclear therapy and device therefor
US20030026384A1 (en) System and method for intensity modulated radiation therapy
CN108671418A (en) Guide of magnetic resonant image device for ion beam radiation therapy
JP4243973B2 (en) Charged particle beam irradiation equipment
KR101374292B1 (en) Apparatus for treating ocular and method for radiating treatment beam thereof
CN112004576B (en) Particle beam guidance system and method and related radiation therapy system
CN112691305B (en) Proton heavy ion beam gating system based on eyeball movement positioning in eyeball tumor radiotherapy
KR101681193B1 (en) Apparatus for treating ocular and method for controlling thereof
JPH02111089A (en) Laser device
JPH07148277A (en) Nonuniform ridge filter system for irradiation with heavy charge particle ray
JP2002291792A (en) Control method and device for eyeball radiation
RU2331446C1 (en) Device for skin neoformation treatment of periorbital area
EP4344733A1 (en) Timing-based methods, systems, and computer readable mediums for a gated linear accelerator
US20230085445A1 (en) Treatment technique for cardiac targets
JP2778641B2 (en) Synchrotron radiation generator
JP2008173298A (en) Charged particle beam irradiation device
JP2815173B2 (en) Laser therapy equipment
KR20220078162A (en) Photothrombotic ischemic stroke investigation system based on multi-dimensional translation stages